Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 110 of the 115 references it cites were found in a registry or an index; 21 of the 28 sources its claims cite were checked for support.

Impact of early life antibiotic and probiotic treatment on gut microbiome and resistome of very-low-birth-weight preterm infants.

Open access
Kiu, Raymond, Darby, Elizabeth M., Alcon-Giner, Cristina, Acuna-Gonzalez, Antia, Camargo, Anny, Lamberte, Lisa E., Phillips, Sarah, Sim, Kathleen, Shaw, Alexander G., Clarke, Paul, van Schaik, Willem, Kroll, J. Simon, Hall, Lindsay J. · 2025 · Nature communications

Published version of a preprint

Abstract

Preterm infants (<32 weeks gestation) are highly susceptible to necrotizing enterocolitis (NEC) and sepsis, which is exacerbated by prolonged antibiotic exposure. In this study, we profiled the gut microbiota and resistome of very-low-birth-weight (VLBW) preterm infants receiving antibiotic and probiotic therapies. We constructed over 300 metagenome-assembled genomes and obtained ~90 isolate genomes via targeted culturomics, allowing strain-level analysis. We also assessed ex vivo horizontal gene transfer (HGT) capacity of multidrug-resistant (MDR) Enterococcus using neonatal gut models. Here we show that probiotic supplementation significantly reduced antibiotic resistance gene prevalence, MDR pathogen load, and restored typical early-life microbiota profile. However, persistent MDR pathogens like Enterococcus, with high HGT potential, underscore the need for continued surveillance. Our findings underscore the complex interplay between antibiotics, probiotics, and HGT in shaping the neonatal microbiome and support further research into probiotics for antimicrobial stewardship in preterm populations.

Overview

CoChat Summary

TL;DR

This study compared 34 very-low-birth-weight preterm infants with and without probiotic supplementation and found that probiotics were associated with a more Bifidobacterium-dominated microbiome and lower antibiotic resistance gene (ARG) burden. Antibiotic exposure and hospital transmission still shaped the neonatal gut resistome, with persistent multidrug-resistant Enterococcus and evidence of plasmid-mediated ARG transfer.

Key findings

  • Across the first 3 weeks of life, the probiotic-supplemented (PS) cohort had significantly higher Bifidobacterium abundance, while the non-probiotic-supplemented (NPS) cohort had more pathobionts including Klebsiella, Enterobacter, Escherichia, Enterococcus, and Staphylococcus.
  • ARG abundance was significantly higher in NPS infants than PS infants across the first 3 weeks; NPS guts also contained more ARG types, especially in weeks 2 and 3.
  • Genome-resolved analysis recovered 322 high-quality MAGs and 89 isolate genomes, then 195 representative strains; among these, Enterococcus, Escherichia, Klebsiella, and Staphylococcus were the four most resistant genera.
  • In metagenomes, plasmid counts were significantly higher in NPS than PS infants, and plasmid replicon count and ARG count were weakly positively correlated overall (τ = 0.33; P = 0.00001), stronger in antibiotic-treated infants (τ = 0.43, P < 0.0001).
  • The ex vivo Enterococcus model showed successful transfer of a ~137 kb mega-plasmid carrying aac6-aph2, which conferred gentamicin resistance to a plasmid-free recipient strain.
  • The study identified 6 Enterococcus strains circulating among infants by 99.9% ANI, including identical strains across unrelated infants in both hospitals, suggesting nosocomial transmission.

Methods

  • Controlled sub-study of a prior observational cohort: 34 VLBW preterm infants from 92 samples; all were human-milk-fed, with PS vs NPS cohorts and antibiotic-treated vs control infants within each cohort.
  • Shotgun metagenomic sequencing of longitudinal faecal samples from weeks 1–3, plus culturomics and genome-resolved metagenomics to recover MAGs and isolate genomes for strain-level microbiome/resistome analysis.
  • ARGs, plasmid replicons, MLST, ANI, HGT, and functional profiling were assessed with sequence-based bioinformatics; an ex vivo neonatal gut model was used to test Enterococcus plasmid transfer.

Limitations

  • The paper states that the 3-week sampling window was relatively short and could not capture longer-term effects of antibiotics and probiotics.
  • The study used samples from two hospital sites, which could introduce site-specific environmental or clinical confounding; the authors say prior work found no significant site effect, but they still acknowledge this as a potential limitation.
  • The paper states that low-abundance ARGs may have been missed because of sequencing coverage limits; it also notes that 7.9% of ARGs were seen in isolate genomes but not in matching metagenomes.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41467-025-62584-2

Cites

110 of 110 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Preterm infant gut microbiome analysis and functional profiling. a Schematic overview of the study design and analyses. b Gut microbiome genus richness (top) and diversity indices (bottom) for 34 infants across two cohorts (n = 19 NPS, n = 15 PS). c NMDS plots of gut metagenomes from 34 preterm infants during the first 3 weeks of life. Differences in microbiota composition between cohorts were tested using PERMANOVA, based on Bray-Curtis distances. The significance (p-values) and the proportion of variance explained (R²) were shown. d Taxonomic relative abundance (%) of 34 infants at genus level, showing only the top 10 most abundant genera across all samples. e Species-level gut microbiome profiles of the same 34 infants, showing bacterial species from the top 10 most abundant genera. f iRep (Index of Replication) of probiotic B. bifidum Infloran strain in the PS cohort. Replication index >1.0 (dashed line) indicates active replication; >1.5 indicates rapid replication. (n = 36 PS samples) g Comparison of relative abundances (%) of three key Bifidobacterium species (where B. bifidum is a key component of probiotic supplementation) between the two cohorts (n = 53 NPS vs n = 39 PS), stratified by week. Mean relative abundances are shown. h Mean proportion of the top 10 most abundant bacterial genera in both cohorts displayed in bubble plots. i NMDS plots of gut microbiome functional profiles for 34 preterm infants, stratified by week and cohort (NPS vs PS). Differences in functional composition between cohorts were tested using PERMANOVA, based on Bray–Curtis distances. The significance (p-values) and the proportion of variance explained (R²) were shown. j Heatmap of 41 significant functional pathways (alpha = 0.05, LDA score >2.0). Inset shows a Venn diagram depicting shared and unique pathways between NPS and PS cohorts based on 407 computationally identified pathways. In (b, f and g), the box plots represent median (line inside the box), interquartile range (IQR; middle 50% of the data, box height), data within 1.5 × IQR (whiskers), and outliers (points). In (b, g and h), statistical significances were assessed using two-sided Wilcoxon tests with Benjamini-Hochberg adjustment for multiple comparisons. Statistical significance: *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001; ns not significant.
Fig. 1 Preterm infant gut microbiome analysis and functional profiling. a Schematic overview of the study design and analyses. b Gut microbiome genus richness (top) and diversity indices (bottom) for 34 infants across two cohorts (n = 19 NPS, n = 15 PS). c NMDS plots of gut metagenomes from 34 preterm infants during the first 3 weeks of life. Differences in microbiota composition between cohorts were tested using PERMANOVA, based on Bray-Curtis distances. The significance (p-values) and the proportion of variance explained (R²) were shown. d Taxonomic relative abundance (%) of 34 infants at genus level, showing only the top 10 most abundant genera across all samples. e Species-level gut microbiome profiles of the same 34 infants, showing bacterial species from the top 10 most abundant genera. f iRep (Index of Replication) of probiotic B. bifidum Infloran strain in the PS cohort. Replication index >1.0 (dashed line) indicates active replication; >1.5 indicates rapid replication. (n = 36 PS samples) g Comparison of relative abundances (%) of three key Bifidobacterium species (where B. bifidum is a key component of probiotic supplementation) between the two cohorts (n = 53 NPS vs n = 39 PS), stratified by week. Mean relative abundances are shown. h Mean proportion of the top 10 most abundant bacterial genera in both cohorts displayed in bubble plots. i NMDS plots of gut microbiome functional profiles for 34 preterm infants, stratified by week and cohort (NPS vs PS). Differences in functional composition between cohorts were tested using PERMANOVA, based on Bray–Curtis distances. The significance (p-values) and the proportion of variance explained (R²) were shown. j Heatmap of 41 significant functional pathways (alpha = 0.05, LDA score >2.0). Inset shows a Venn diagram depicting shared and unique pathways between NPS and PS cohorts based on 407 computationally identified pathways. In (b, f and g), the box plots represent median (line inside the box), interquartile range (IQR; middle 50% of the data, box height), data within 1.5 × IQR (whiskers), and outliers (points). In (b, g and h), statistical significances were assessed using two-sided Wilcoxon tests with Benjamini-Hochberg adjustment for multiple comparisons. Statistical significance: *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001; ns not significant.CC BY · PubMed Central
Fig. 2 In-depth profiling of the neonatal preterm infant gut resistome. a Schematic timeline of antibiotic regimen. b Comparison of antimicrobial resistance genes (ARGs) NPS vs PS cohorts (overall n = 53 NPS, n = 39 PS). c Comparison of ARG classes count between NPS and PS (overall n = 53 NPS, n = 39 PS). d Proportions of ARG types (NPS vs PS). The inset bar chart shows the mean ARG count. e Distribution of individual ARG profiles (NPS vs PS). f Venn diagram showing the number and percentage of unique and shared ARGs. g Comparison of Chao1 (genus richness) and Shannon (ecological diversity) indices between antibiotic-treated (n = 27 NPS, n = 31 PS) and control (untreated; n = 26 NPS, n = 8 PS) groups. h Gut microbiome dynamics over the first three weeks of life, showing the top 10 genera. i Changes in taxonomic abundance (top 10 genera) in the antibiotic-treated versus control groups (NPS + PS). Shaded area indicates the antibiotic treatment period (median: 3 days). j Comparison of the number of ARGs between antibiotic-treated (n = 27 NPS, n = 31 PS) and control (untreated; n = 26 NPS, n = 8 PS) groups in both cohorts. k Comparison of the ARG count between NPS (n = 27 Antibiotic, n = 26 Control) and PS (n = 31 Antibiotic, n = 8 Control) cohorts, stratified by antibiotic exposure. l Correlation plot of Shannon diversity index versus ARG number (NPS vs PS). τ represents Kendall’s rank correlation coefficient. Shaded error bands indicate 95% confidence intervals around the regression lines. m Kendall’s correlation between the number of ARGs and relative abundance of the top 10 most abundant genera. n Genomic mapping of an extracted contig containing the mcr-9.1 gene against a public reference mcr-9.1 gene from E. coli, showing 100% nucleotide identity. In (b, c, g, j and k), the box plots represent median (line inside the box), interquartile range (IQR; middle 50% of the data, box height), data within 1.5 × IQR (whiskers), and outliers (points). In (b, c, d, g, i, j and k), statistical significance was assessed using two-sided Wilcoxon tests with Benjamini–Hochberg correction. In (l and m), correlations were assessed using two-sided Kendall’s rank correlation test. Statistical significance: *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001; ns not significant.
Fig. 2 In-depth profiling of the neonatal preterm infant gut resistome. a Schematic timeline of antibiotic regimen. b Comparison of antimicrobial resistance genes (ARGs) NPS vs PS cohorts (overall n = 53 NPS, n = 39 PS). c Comparison of ARG classes count between NPS and PS (overall n = 53 NPS, n = 39 PS). d Proportions of ARG types (NPS vs PS). The inset bar chart shows the mean ARG count. e Distribution of individual ARG profiles (NPS vs PS). f Venn diagram showing the number and percentage of unique and shared ARGs. g Comparison of Chao1 (genus richness) and Shannon (ecological diversity) indices between antibiotic-treated (n = 27 NPS, n = 31 PS) and control (untreated; n = 26 NPS, n = 8 PS) groups. h Gut microbiome dynamics over the first three weeks of life, showing the top 10 genera. i Changes in taxonomic abundance (top 10 genera) in the antibiotic-treated versus control groups (NPS + PS). Shaded area indicates the antibiotic treatment period (median: 3 days). j Comparison of the number of ARGs between antibiotic-treated (n = 27 NPS, n = 31 PS) and control (untreated; n = 26 NPS, n = 8 PS) groups in both cohorts. k Comparison of the ARG count between NPS (n = 27 Antibiotic, n = 26 Control) and PS (n = 31 Antibiotic, n = 8 Control) cohorts, stratified by antibiotic exposure. l Correlation plot of Shannon diversity index versus ARG number (NPS vs PS). τ represents Kendall’s rank correlation coefficient. Shaded error bands indicate 95% confidence intervals around the regression lines. m Kendall’s correlation between the number of ARGs and relative abundance of the top 10 most abundant genera. n Genomic mapping of an extracted contig containing the mcr-9.1 gene against a public reference mcr-9.1 gene from E. coli, showing 100% nucleotide identity. In (b, c, g, j and k), the box plots represent median (line inside the box), interquartile range (IQR; middle 50% of the data, box height), data within 1.5 × IQR (whiskers), and outliers (points). In (b, c, d, g, i, j and k), statistical significance was assessed using two-sided Wilcoxon tests with Benjamini–Hochberg correction. In (l and m), correlations were assessed using two-sided Kendall’s rank correlation test. Statistical significance: *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001; ns not significant.CC BY · PubMed Central
Fig. 3 Strain-level resistome analysis. a Neighbour-joining tree of 195 representative bacterial strains (post-genome dereplication) aligned with clinical metadata, ARG profiles (by resistance class), and ARG counts, the original dataset comprises both isolate genomes (n = 89) and metagenome-assembled genomes (MAGs; n = 322), totalling 411 individual bacterial genomes. b Comparison of distinct ARG counts per strain across the ten most abundant genera. Statistical analysis was performed using the Kruskal–Wallis test followed by Dunn’s post hoc test (FDR-adjusted). Significance was compared against Bifidobacterium. **P < 0.01, ****P < 0.0001. Data are presented as mean ± SEM. n represents number of representative strain-level genomes (total n = 162). c Comparison of ARG counts per strain between the four most resistant genera: Enterococcus, Escherichia, Klebsiella and Staphylococcus. Cohort comparisons were made using two-sided Wilcoxon tests with Benjamini–Hochberg correction, no difference were statistically significant. The box plot represents median (line inside the box), interquartile range (IQR; middle 50% of the data, box height), data within 1.5 × IQR (whiskers), and outliers (points). n represents number of representative strain-level genomes (total n = 162). d Profiles of multidrug resistance (MDR) efflux pumps (n = 20) across genomes (n = 204) of the four most resistant genera: Enterococcus, Escherichia, Klebsiella and Staphylococcus. e (Top) Proportions of ARG resistance classes per genome (n = 204) in both NPS and PS cohorts. (Bottom) Proportions of MDR versus non-MDR genomes in NPS and PS cohorts. MDR was defined as harbouring predicted ARGs conferring resistance to three or more antibiotic classes. Statistical significance was assessed using two-sided Fisher’s exact test. ****P < 0.0001. f Multi-locus sequence typing (MLST) analysis of key pathobiont genomes (n = 193) from the four most resistant genera. Pie charts display genus-specific proportions of unique (non-shared) and shared sequence types between NPS and PS cohorts. Additional surface antigen typing (Kaptive) for Klebsiella spp. is shown in the inset box.
Fig. 3 Strain-level resistome analysis. a Neighbour-joining tree of 195 representative bacterial strains (post-genome dereplication) aligned with clinical metadata, ARG profiles (by resistance class), and ARG counts, the original dataset comprises both isolate genomes (n = 89) and metagenome-assembled genomes (MAGs; n = 322), totalling 411 individual bacterial genomes. b Comparison of distinct ARG counts per strain across the ten most abundant genera. Statistical analysis was performed using the Kruskal–Wallis test followed by Dunn’s post hoc test (FDR-adjusted). Significance was compared against Bifidobacterium. **P < 0.01, ****P < 0.0001. Data are presented as mean ± SEM. n represents number of representative strain-level genomes (total n = 162). c Comparison of ARG counts per strain between the four most resistant genera: Enterococcus, Escherichia, Klebsiella and Staphylococcus. Cohort comparisons were made using two-sided Wilcoxon tests with Benjamini–Hochberg correction, no difference were statistically significant. The box plot represents median (line inside the box), interquartile range (IQR; middle 50% of the data, box height), data within 1.5 × IQR (whiskers), and outliers (points). n represents number of representative strain-level genomes (total n = 162). d Profiles of multidrug resistance (MDR) efflux pumps (n = 20) across genomes (n = 204) of the four most resistant genera: Enterococcus, Escherichia, Klebsiella and Staphylococcus. e (Top) Proportions of ARG resistance classes per genome (n = 204) in both NPS and PS cohorts. (Bottom) Proportions of MDR versus non-MDR genomes in NPS and PS cohorts. MDR was defined as harbouring predicted ARGs conferring resistance to three or more antibiotic classes. Statistical significance was assessed using two-sided Fisher’s exact test. ****P < 0.0001. f Multi-locus sequence typing (MLST) analysis of key pathobiont genomes (n = 193) from the four most resistant genera. Pie charts display genus-specific proportions of unique (non-shared) and shared sequence types between NPS and PS cohorts. Additional surface antigen typing (Kaptive) for Klebsiella spp. is shown in the inset box.CC BY · PubMed Central
Fig. 4 Mobilome analysis and potential strain dissemination. a Plasmid profiles of preterm infant gut-associated bacterial strains (n = 195) aligned with a strain-level neighbour-joining tree, cohort data, genome type, and bacterial taxonomy (highlighting the top 10 most abundant genera). Plasmid and ARG counts are also shown for comparison. b Comparison of gut microbiome plasmid counts between NPS (n = 53) and PS (n = 39) cohorts. *P < 0.05. c Comparison of plasmid counts between antibiotic-treated (n = 27 NPS, n = 31 PS) and control (untreated; n = 26 NPS, n = 8 PS) groups, stratified by cohort (NPS vs PS). ns, not significant. d Plasmid count comparison between antibiotic-treated (n = 58) and control (n = 34) groups across all preterm infant metagenome samples. ns not significant. e Correlation plot of ARG count versus plasmid count across all preterm infant metagenome samples. The scatter plot is coloured by antibiotic exposure: purple indicates antibiotic-treated infants; grey denotes untreated controls. τ represents Kendall’s rank correlation coefficient. Shaded error bands indicate 95% confidence intervals around the regression lines. Correlation was assessed using a two-sided Kendall’s rank correlation test. f Horizontal gene transfer (HGT) events per genome comparison across all bacterial genomes (n = 411) between antibiotic-treated (n = 237) and control (n = 174) infants. ****P < 0.0001. g Comparison of plasmid replicon counts per strain across the ten most abundant genera. Statistical significance was assessed using the Kruskal–Wallis test followed by Dunn’s post hoc test (FDR-adjusted). Significance was determined relative to Bifidobacterium. *P < 0.05, ****P < 0.0001. Data are presented as mean ± SEM. n represents number of representative strain-level genomes (n = 162). h Potential dissemination or circulation of Enterococcus strains among preterm infants in NICUs at two separate hospital sites, with temporal information indicated. Each phylogenetic cluster represents clonal strains. Strain-level clustering defined by ANI > 99.9%. Each infant symbol represents an individual (singleton), unless otherwise indicated. In (b–d and f), the box plots represent median (line inside the box), interquartile range (IQR; middle 50% of the data, box height), data within 1.5 × IQR (whiskers), and outliers (points). In (b–d and f), statistical significance was assessed using two-sided Wilcoxon tests with Benjamini–Hochberg correction.
Fig. 4 Mobilome analysis and potential strain dissemination. a Plasmid profiles of preterm infant gut-associated bacterial strains (n = 195) aligned with a strain-level neighbour-joining tree, cohort data, genome type, and bacterial taxonomy (highlighting the top 10 most abundant genera). Plasmid and ARG counts are also shown for comparison. b Comparison of gut microbiome plasmid counts between NPS (n = 53) and PS (n = 39) cohorts. *P < 0.05. c Comparison of plasmid counts between antibiotic-treated (n = 27 NPS, n = 31 PS) and control (untreated; n = 26 NPS, n = 8 PS) groups, stratified by cohort (NPS vs PS). ns, not significant. d Plasmid count comparison between antibiotic-treated (n = 58) and control (n = 34) groups across all preterm infant metagenome samples. ns not significant. e Correlation plot of ARG count versus plasmid count across all preterm infant metagenome samples. The scatter plot is coloured by antibiotic exposure: purple indicates antibiotic-treated infants; grey denotes untreated controls. τ represents Kendall’s rank correlation coefficient. Shaded error bands indicate 95% confidence intervals around the regression lines. Correlation was assessed using a two-sided Kendall’s rank correlation test. f Horizontal gene transfer (HGT) events per genome comparison across all bacterial genomes (n = 411) between antibiotic-treated (n = 237) and control (n = 174) infants. ****P < 0.0001. g Comparison of plasmid replicon counts per strain across the ten most abundant genera. Statistical significance was assessed using the Kruskal–Wallis test followed by Dunn’s post hoc test (FDR-adjusted). Significance was determined relative to Bifidobacterium. *P < 0.05, ****P < 0.0001. Data are presented as mean ± SEM. n represents number of representative strain-level genomes (n = 162). h Potential dissemination or circulation of Enterococcus strains among preterm infants in NICUs at two separate hospital sites, with temporal information indicated. Each phylogenetic cluster represents clonal strains. Strain-level clustering defined by ANI > 99.9%. Each infant symbol represents an individual (singleton), unless otherwise indicated. In (b–d and f), the box plots represent median (line inside the box), interquartile range (IQR; middle 50% of the data, box height), data within 1.5 × IQR (whiskers), and outliers (points). In (b–d and f), statistical significance was assessed using two-sided Wilcoxon tests with Benjamini–Hochberg correction.CC BY · PubMed Central
Fig. 5 Gentamicin-resistant plasmid transfer study in Enterococcus. a Schematic of the ex vivo study workflow and associated analyses, illustrating the study design within a 24-well plate format. b Antibiotic resistance gene profiling of donor and recipient strains. Colonies were individually picked from selective agar plates supplemented with the appropriate antibiotics and subjected to whole-genome sequencing using a combined long-read and short-read sequencing platform. A neighbour-joining tree was constructed to depict the relatedness between isolate genomes, aligned with plasmid replicons predicted within the genomes alongside their calculated genome sizes. The inset (top left) shows shotgun metagenomic contents (microbial taxa) of the infant faecal slurry utilised in the gut model experiment. Gene aac6-Ii is known to be a chromosomally encoded aminoglycoside acetyltransferase in Enterococcus spp. ARMA-59 and ARMA-73 are preterm-derived isolates (donor strains) whereas 64-3 (or, 64/3) is a plasmid-free laboratory strain. c Comparison of the computationally extracted antibiotic resistance gene aac-aph2 from the representative donor strain B1 and recipient (transformant) strains D1-1 and D3-1. d Comparison of complete contig sequences encoding the gentamicin resistance gene aac6-aph2, predicted to be either whole or partial sequences of potential mobile genetic elements, including plasmids.
Fig. 5 Gentamicin-resistant plasmid transfer study in Enterococcus. a Schematic of the ex vivo study workflow and associated analyses, illustrating the study design within a 24-well plate format. b Antibiotic resistance gene profiling of donor and recipient strains. Colonies were individually picked from selective agar plates supplemented with the appropriate antibiotics and subjected to whole-genome sequencing using a combined long-read and short-read sequencing platform. A neighbour-joining tree was constructed to depict the relatedness between isolate genomes, aligned with plasmid replicons predicted within the genomes alongside their calculated genome sizes. The inset (top left) shows shotgun metagenomic contents (microbial taxa) of the infant faecal slurry utilised in the gut model experiment. Gene aac6-Ii is known to be a chromosomally encoded aminoglycoside acetyltransferase in Enterococcus spp. ARMA-59 and ARMA-73 are preterm-derived isolates (donor strains) whereas 64-3 (or, 64/3) is a plasmid-free laboratory strain. c Comparison of the computationally extracted antibiotic resistance gene aac-aph2 from the representative donor strain B1 and recipient (transformant) strains D1-1 and D3-1. d Comparison of complete contig sequences encoding the gentamicin resistance gene aac6-aph2, predicted to be either whole or partial sequences of potential mobile genetic elements, including plasmids.CC BY · PubMed Central

Verification

Claims the paper makes

11 Valid · 0 Not valid · 2 Not checked · 100 Own results and interpretations

55 more claims

Create a free account to see all 113 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 44
  • Probably not a substantial claim. 14

Create a free account to see these claims.

Citations

Cites

Show all 115 references

Cited by

See all 36

Metadata

Authors
Kiu, R., Darby, E. M., Alcon-Giner, C., Acuna-Gonzalez, A., Camargo, A., Lamberte, L. E., Phillips, S., Sim, K., Shaw, A. G., Clarke, P., van Schaik, W., Kroll, J. S., & Hall, L. J.
Affiliations
  • Norwich Research Park (GB)
  • University of Birmingham (GB)
  • Imperial College London (GB)
  • University of East Anglia (GB)
Corresponding author
  • Kiu, Raymond
  • Hall, Lindsay J.
Venue
Nature communications
Published
2025-08-14
Volume
16
Issue
1
Pages
7569-7569
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4413140743
Cited by
36
References
115
Citations by year
2026: 32 · 2025: 5
FWCI
11.57
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, other-oa)
  • PubMed (publishedVersion)
  • UEA Digital Repository (University of East Anglia) (acceptedVersion, cc-by)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by)
  • PubMed Central (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Wellcome Trust (100974/C/13/Z)
  • RCUK | Biotechnology and Biological Sciences Research Council (BB/R012490/1, BB/X011054/1, BB/S017941/1)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Nursing › Nutrition and Dietetics › Infant Nutrition and Health
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
Keywords
preterm infants, very low birth weight infants, probiotics, antibiotics, gut microbiota, resistome, antibiotic resistance genes, horizontal gene transfer
MeSH terms
Gastrointestinal Microbiome, Anti-Bacterial Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impact of early life antibiotic and probiotic treatment on gut microbiome and resistome of very-low-birth-weight preterm infants. https://app.cochat.ai/papers/10.1038/s41467-025-62584-2
The paper
Kiu, R., Darby, E. M., Alcon-Giner, C., Acuna-Gonzalez, A., Camargo, A., Lamberte, L. E., Phillips, S., Sim, K., Shaw, A. G., Clarke, P., van Schaik, W., Kroll, J. S., & Hall, L. J. (2025). Impact of early life antibiotic and probiotic treatment on gut microbiome and resistome of very-low-birth-weight preterm infants. Nature communications. https://doi.org/10.1038/s41467-025-62584-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.